APA (7th ed.) Citation

Giovannoni, G., Hawkes, C., Lechner-Scott, J., Levy, M., Waubant, E., & Gold, J. (2020). The COVID-19 pandemic and the use of MS disease-modifying therapies. Multiple sclerosis and related disorders, 39, 102073. https://doi.org/10.1016/j.msard.2020.102073

Chicago Style (17th ed.) Citation

Giovannoni, Gavin, Chris Hawkes, Jeannette Lechner-Scott, Michael Levy, Emmanuelle Waubant, and Julian Gold. "The COVID-19 Pandemic and the Use of MS Disease-modifying Therapies." Multiple Sclerosis and Related Disorders 39 (2020): 102073. https://doi.org/10.1016/j.msard.2020.102073.

MLA (9th ed.) Citation

Giovannoni, Gavin, et al. "The COVID-19 Pandemic and the Use of MS Disease-modifying Therapies." Multiple Sclerosis and Related Disorders, vol. 39, 2020, p. 102073, https://doi.org/10.1016/j.msard.2020.102073.